Further research is necessary to clarify the peptides pharmacology, toxicology, and potential clinical relevance
Suitability depends on your medical history, and the post says a provider should supervise baseline metabolic screening and periodic reassessment
Start using it
You search online for a simple reconstitution chart and find conflicting information everywhere
I also WILL NOT endorse the use of either peptide, sourced legitimately or not, without monitoring key markers or a thorough understanding of the pharmacology powering either peptide
In a previous double-blind placebo-controlled phase II trial, 42 self-sufficient subjects (with a score of 3+ on the ALSFRS-R items for swallowing, cutting food and handling utensils, and walking) with ALS [10] received ALCAR 3 g/day and 40 received placebo in an equivalent dose, and were followed for 12 months or until death [11]